BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17564287)

  • 1. Drug-eluting stent thrombosis: an oversensationalized but unresolved problem?
    Latib A; Chieffo A; Colombo A
    Monaldi Arch Chest Dis; 2007 Mar; 68(1):1-5. PubMed ID: 17564287
    [No Abstract]   [Full Text] [Related]  

  • 2. Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force.
    Hodgson JM; Stone GW; Lincoff AM; Klein L; Walpole H; Bottner R; Weiner BH; Leon MB; Feldman T; Babb J; Dehmer GJ;
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):327-33. PubMed ID: 17219373
    [No Abstract]   [Full Text] [Related]  

  • 3. Late thrombosis following treatment of in-stent restenosis with drug-eluting stents after discontinuation of antiplatelet therapy.
    Waters RE; Kandzari DE; Phillips HR; Crawford LE; Sketch MH
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):520-4. PubMed ID: 15973673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stent thrombosis following the STAR technique in a complex RCA chronic total occlusion.
    Erlich I; Strauss BH; Butany J
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):708-12. PubMed ID: 17039512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late thrombosis of sirolimus-eluting stents following noncardiac surgery.
    Nasser M; Kapeliovich M; Markiewicz W
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):516-9. PubMed ID: 15926177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: a meta-analysis.
    Bavry AA; Kumbhani DJ; Helton TJ; Bhatt DL
    J Am Coll Cardiol; 2005 Mar; 45(6):941-6. PubMed ID: 15766833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The bioresorbable coronary stent: a revolution].
    Koegler F; De Benedetti E
    Rev Med Suisse; 2013 Apr; 9(381):775-8. PubMed ID: 23659156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-eluting stents and stent thrombosis: a cause for concern?
    Wernick MH; Jeremias A; Carrozza JP
    Coron Artery Dis; 2006 Dec; 17(8):661-5. PubMed ID: 17119373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary brachytherapy in the drug-eluting stent era: don't bury it alive.
    Waksman R; Weinberger J
    Circulation; 2003 Jul; 108(4):386-8. PubMed ID: 12885731
    [No Abstract]   [Full Text] [Related]  

  • 13. Eptifibatide-eluting stent as an antiproliferative and antithrombotic agent: in vitro evaluation.
    Chitkara K; Hogrefe K; Vasa-Nicotera M; Swanson N; Gershlick AH
    J Invasive Cardiol; 2006 Sep; 18(9):417-22. PubMed ID: 16954580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction.
    Brodie B; Pokharel Y; Garg A; Kissling G; Hansen C; Milks S; Cooper M; McAlhany C; Stuckey T
    JACC Cardiovasc Interv; 2012 Oct; 5(10):1043-51. PubMed ID: 23078734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late stent thrombosis--the "vulnerable" stent.
    Waksman R
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):54-6. PubMed ID: 17585385
    [No Abstract]   [Full Text] [Related]  

  • 17. Stent thrombosis following 2 drug-eluting stent implantations for coronary bifurcation lesion: a single-center analysis.
    Gao Z; Xu B; Yang Y; Chen J; Qiao S; Li JJ; Qin X; Wu Y; Yao M; Yuan J; Chen J; Liu H; Dai J; Gao RL
    J Interv Cardiol; 2010 Aug; 23(4):346-51. PubMed ID: 20718906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of residual stenosis after coronary stent implantation on development of restenosis and stent thrombosis.
    Colombo A
    Am J Cardiol; 2003 Oct; 92(8):1013; author reply 1013-4. PubMed ID: 14556889
    [No Abstract]   [Full Text] [Related]  

  • 19. Very late [corrected] thrombosis of a sirolimus-eluting stent.
    Henderson D; Gunalingam B
    Catheter Cardiovasc Interv; 2006 Sep; 68(3):406-8. PubMed ID: 16892439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.